Target intelligence / Profile preview

PABPC1L2B antisense RNA 1 (head to head) (PABPC1L2B-AS1)

Target
PABPC1L2B-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA (head to head orientation)
01

Overview

PABPC1L2B antisense RNA 1 (PABPC1L2B-AS1) is a long non-coding RNA (lncRNA) gene found on the X chromosome, transcribed in a head-to-head (bidirectional) antisense orientation. It consists of four exons and has a transcript size of 1167 bases. Computational assessments and database annotation confirm its non-coding nature, and there is no evidence of protein-coding potential. There is currently no literature describing its biological function, disease relevance, or association with drug interactions. This transcript is cataloged in several genomic databases under multiple identifiers, but its molecular and clinical significance is unknown. PABPC1L2B-AS1 shares nomenclature similarity to protein-coding genes involved in mRNA stabilization/translation, such as PABPC1, but is distinct in sequence, regulatory architecture, and lacks evidence of translation or direct involvement in these processes. The lack of available literature and functional reports in major databases indicates this is a non-protein-coding locus with no current therapeutic, biomarker, or disease relevance. Summary: PABPC1L2B antisense RNA 1 (PABPC1L2B-AS1) is a catalogued long non-coding antisense RNA gene without described biological function, disease roles, or drug interactions. It should not be considered a pharmacological target or biomarker at present, and information about it is extremely limited or absent in the scientific literature.

Other names
PABPC1L2B-AS1PABPC1L2B antisense RNA 1 (head to head)NONHSAT137515NR_110398ENST00000416989.2NR_110398.1ENSG00000226725.2RP11-493K23.1
02

Mechanism of action

None (No known mechanism of drug action because it is not an established drug target)

03

Biological functions

Other (No known function; general for lncRNA: regulation of gene expression, but no specific data for this transcript)
04

Disease associations

Other (No known direct disease association or implication)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on PABPC1L2B antisense RNA 1 (head to head) (PABPC1L2B-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PABPC1L2B antisense RNA 1 (head to head) (PABPC1L2B-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call